Commentary on a critique for the Journal of Psychopharmacology: NICE - Excellence or eccentricity? Reflections on the z-drugs as hypnotics review

Journal of Psychopharmacology

Volumn 21, Issue 1, 2007, Pages 114-117

  Capua, T ^a   Shapiro, C M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Benzodiazepines; Insomnia; Zaleplon; Zolpidem; Zopiclone

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CLONAZEPAM; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; NITRAZEPAM; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

COMORBIDITY; DROWSINESS; DRUG COST; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; HEALTH CARE COST; HIP FRACTURE; HUMAN; INSOMNIA; MEMORY CONSOLIDATION; MUSCLE RELAXATION; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REM SLEEP; SEDATION; SLOW WAVE SLEEP; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ACETAMIDES; BENZODIAZEPINES; GREAT BRITAIN; HUMANS; HYPNOTICS AND SEDATIVES; PIPERAZINES; PRACTICE GUIDELINES; PYRIDINES; PYRIMIDINES; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 33845774436     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106072670     Document Type: Note

References (29)

1. Agnoli A, Manna V, Martucci N (1989) Double-blind study on the hypnotic and anti-anxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia. Int J Clin Pharmacol Res 9 (4). 277-281
2. Bateson A N (2004) The benzodiazepine site of the GABAA receptor: an old target with new potential? Sleep Med 5 (suppl. 1). S9 - S15
3. Chilcott L A, Shapiro C M (1996) The socioeconomic impact of insomnia. An overview. Pharmacoeconomics 10 (suppl, 1). 1-14
4. Dement W C, Shapiro C M (1993) ABC of sleep disorders. Impact and epidemiology of sleep disorders. BMJ 12: 1604-1607
5. Dundar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, Bogg J, Dickson R, Walley T (2004) Newer hypnotic drugs for the short-term management of insomina: a systematic review and economic evaluation. Health Technol Assess 8: iii - x, 1-125
6. Evans S M, Funderburk F R, Griffiths R R (1990) Zolpidem and triazolem in humans: behavioural and subjective effects and abuse liability. J Pharmacol Exp Ther 225 (3). 1246-1255
7. Feinberg I, Fein G, Walker J M, Price L J, Floyd T C, March J D (1977) Flurazepam effects on slow-wave sleep: stage 4 suppressed but number of delta waves constant. Science 198: 847-848
8. Fleming J A, Bourgouin J, Hamilton P (1988) A sleep laboratory evaluation of the long-term efficacy of zopiclone. Can J Psychiatry 33: 103-107
9. Follesa P, Mancuso L, Biggio F, Cagetti E, Franco M, Trapani G, Biggio G (2002) Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem. Neuropharmacology 42 (2). 191-198
10. Gaillard J M, Schultz P, Tissot R (1973) Effects of three benzodiazepines (nitrazepam, flunitrazepam and bromozepam) on sleep normal subjects, studied with an automatic sleep scoring system. Pharmacopsychiatry 6: 207-209
11. Hajak G, Clarenbach P, Fischer W, Haase W, Ruther E (1994) Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo. Int Clin Psychopharmacol 9: 251-261
12. Hajak G, Muller W E, Wittchen H U, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98: 1371-1378
13. Holm K J, Goa K L (2000) Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 59 (4). 865-889
14. Jaffe J H, Bloor R, Crome I, Carr M, Alam F, Simmons A, Meyer R E (2004) A postmarketing study of relative abuse liability of hypnotic sedative drugs. Addiction 99 (2). 165-173
15. James S P, Mendelson W B (2004) The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 65: 752-755
16. Johnson L C, Hanson K, Bickford R G (1976) Effect of flurazepam on sleep spindles and K-complexes. Electroenceph Clin Neurophysiol 40: 67-77
17. Klimm H D, Dreyfus J F, Delmotte M (1987) Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 10 (suppl. 1). 73-78
18. Montplaisir J, Hawa R, Moller H, Morin C, Fortin M, Matte J, Reinish L, Shapiro C M (2003) Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Hum Psychopharmacol 18 (1). 29-38
19. Nelson L E, Guo T Z, Lu J, Saper C B, Franks N P, Maze M (2002) The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 5: 979-984
20. Nutt D J (2005) Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 10 (1). 49-56
21. Poyares D, Guilleminault C, Ohayon M, Tufik S (2004) Chronic benzodiazepine usage and withdrawal in insomnia patients. J Psych Res 38: 327-334
22. Rudolph U, Mohler H (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44: 475-498
23. Salva P, Costa J (1995) Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet 29 (3). 142-153
24. Shapiro C M (1982) Energy expenditure and restorative sleep. Biological Psychology 15: 229-239
25. Shapiro C M, Sherman D, Peck D F (1995) Withdrawal from benzodiazepines by initially switching to Zopiclone. European Psychiatry 10 (suppl. 3). 145s - 151s
26. Shapiro G, Shen J, Shapiro C M (2004) Sleep changes in the depressed older adult: implications for management. Geriatrics and Aging 7: 25-31
27. Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F (2001). A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. Eur Arch Psychiatry Clin Neurosci 251 (3). 117-123
28. Wagner J, Wagner M L (2000) Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev 4: 551-581
29. Weerts E M, Ator N A, Grech D M, Griffiths R R (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285 (1). 41-53